S&P 500 & Eli Lilly and Company
12 shared events · Importance 5 · Last updated Jun 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Domestic
S&P 500: The S&P 500 advanced, moving above key technical levels, reflecting positive market sentiment driven by Middle East peace talks and strong performance in certain sectors.
Eli Lilly and Company: Eli Lilly and Company rose after the United States — Food and Drug Administration approved its new weight loss pill, Foundayo.
Apr 01, 2026 · 14 articles
Business
S&P 500: The S&P 500 gained, reaching new records, as U.S. stocks bounced back due to easing bond market pressure and strong tech earnings, reflecting a positive trend in the broader U.S. market.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
May 20, 2026 · 72 articles
Business
S&P 500: Fell 1.6% in a single session, back to early May levels; first back-to-back drop in three weeks.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Apr 20, 2026 · 344 articles
International
S&P 500: The S&P 500 notched its ninth straight weekly gain and monthly advance, driven by hopes of progress toward a peaceful resolution to the Iran war and a robust earnings season.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 18, 2026 · 309 articles
International
S&P 500: The S&P 500 notched its ninth straight weekly gain and monthly advance, driven by hopes of progress toward a peaceful resolution to the Iran war and a robust earnings season.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 27, 2026 · 101 articles
Business
S&P 500: The S&P 500 posted a weekly decline after nine straight weeks of gains, reflecting broader market concerns despite being up 8% for the year.
Eli Lilly and Company: Eli Lilly and Company is mentioned as one of the companies that SpaceX's valuation will surpass, emphasizing the magnitude of SpaceX's market entry.
Mar 09, 2018 · 538 articles
Domestic
S&P 500: The S&P 500 edged up to an all-time closing high, reflecting overall market strength despite some concerns about AI-related stocks.
Eli Lilly and Company: Eli Lilly and Company saw gains that helped offset drops in other sectors, contributing to the overall positive market performance.
Dec 11, 2025 · 7 articles
International
S&P 500: The S&P 500 also reached records, but later declined. It reflects overall market reaction to geopolitical developments.
Eli Lilly and Company: Eli Lilly and Company raised its forecast, boosting healthcare stocks. It is not connected to the event.
Mar 09, 2018 · 316 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how S&P 500 and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard